Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessResearch

Harm reduction and equity of access to care for French prisoners: a review

Laurent Michel1,2,3* email, M Patrizia Carrieri4,5* email and Alex Wodak6 email

Health and Medical Research National Institute, Research Unit 669, Paris, France

University of Paris-Sud and University Paris Descartes, umr-s0669, Paris, France

Emile Roux Hospital, Limeil-Brévannes, France

Inserm umr912 "Economic & Social Sciences, Health Systems & Societies", Marseille, France

Southeastern Health Regional Observatory (ORS-PACA), Marseille, France

St. Vincent's Hospital, Sydney, Australia

author email corresponding author email* Contributed equally

Harm Reduction Journal 2008, 5:17doi:10.1186/1477-7517-5-17

Published: 21 May 2008

Abstract

Background

Despite France being regarded as a model of efficient harm reduction policy and equity of access to care in the general community, the health of French inmates is a critical issue, as harm reduction measures are either inaccessible or only partially implemented in French prisons.

Method

Using specific inclusion and exclusion criteria, information was collected and analyzed about HIV, HBV and HCV prevalence, risk practices, mortality, access to harm reduction measures and care for French prison inmates.

Results

Data about the occurrence of bloodborne diseases, drug use and access to care in prisons remain limited and need urgent updating. Needle exchange programs are not yet available in French prisons and harm reduction interventions and access to OST remain limited or are heterogeneous across prisons. The continuity of care at prison entry and after release remains problematic and should be among the primary public health priorities for French prisoners.

Conclusion

Preventive and harm reduction measures should be urgently introduced at least as pilot programs. The implementation of such measures, not yet available in French prisons, is not only a human right for prison inmates but can also provide important public health benefits for the general population.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.